Literature DB >> 17020536

Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.

Guillaume Boucher1, Bilal Said, Elizabeth L Ostler, Marina Resmini, Keith Brocklehurst, Gerard Gallacher.   

Abstract

A kinetically homogeneous anti-phosphate catalytic antibody preparation was shown to catalyse the hydrolysis of a series of O-aryl N-methyl carbamates containing various substituents in the 4-position of the O-phenyl group. The specific nature of the antibody catalysis was demonstrated by the adherence of these reactions to the Michaelis-Menten equation, the complete inhibition by a hapten analogue, and the failure of the antibody to catalyse the hydrolysis of the 2-nitrophenyl analogue of the 4-nitrophenylcarbamate substrate. Hammett sigma-rho analysis suggests that both the non-catalysed and antibody-catalysed reactions proceed by mechanisms in which development of the aryloxyanion of the leaving group is well advanced in the transition state of the rate-determining step. This is probably the ElcB (elimination-addition) mechanism for the non-catalysed reaction, but for the antibody-catalysed reaction might be either ElcB or B(Ac)2 (addition-elimination), in which the elimination of the aryloxy group from the tetrahedral intermediate has become rate-determining. This result provides evidence of the dominance of recognition of phenolate ion character in the phosphate hapten in the elicitation process, and is discussed in connection with data from the literature that suggest a B(Ac)2 mechanism, with rate-determining formation of the tetrahedral intermediate for the hydrolysis of carbamate substrates catalysed by an antibody elicited by a phosphonamidate hapten in which phenolate anion character is minimized. The present paper contributes to the growing awareness that small differences in the structure of haptens can produce large differences in catalytic characteristics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17020536      PMCID: PMC1770849          DOI: 10.1042/BJ20060551

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions.

Authors:  C M Topham; S Gul; M Resmini; S Sonkaria; G Gallacher; K Brocklehurst
Journal:  J Theor Biol       Date:  2000-05-21       Impact factor: 2.691

2.  Binding Energy and Catalysis: The Implications for Transition-State Analogs and Catalytic Antibodies.

Authors:  Mary M. Mader; Paul A. Bartlett
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

3.  Kinetic and titration methods for determination of active site contents of enzyme and catalytic antibody preparations.

Authors:  K Brocklehurst; M Resmini; C M Topham
Journal:  Methods       Date:  2001-06       Impact factor: 3.608

Review 4.  Critical analysis of antibody catalysis.

Authors:  D Hilvert
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 5.  Polyclonal catalytic antibodies.

Authors:  Elizabeth L Ostler; Marina Resmini; Keith Brocklehurst; Gerard Gallacher
Journal:  J Immunol Methods       Date:  2002-11-01       Impact factor: 2.303

6.  Polyclonal antibody-catalysed hydrolysis of a beta-lactam.

Authors:  Elizabeth L Ostler; Marina Resmini; Guillaume Boucher; Nickolas Romanov; Keith Brocklehurst; Gerard Gallacher
Journal:  Chem Commun (Camb)       Date:  2002-02-07       Impact factor: 6.222

7.  Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.

Authors:  Sanjiv Sonkaria; Guillaume Boucher; José Flórez-Olvarez; Bilal Said; Syeed Hussain; Elizabeth L Ostler; Sheraz Gul; Emrys W Thomas; Marina Resmini; Gerard Gallacher; Keith Brocklehurst
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

8.  Characterization of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg side chains as hydrogen-bond donors.

Authors:  M Resmini; R Vigna; C Simms; N J Barber; E P Hagi-Pavli; A B Watts; C Verma; G Gallacher; K Brocklehurst
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

9.  A polyclonal antibody preparation with Michaelian catalytic properties.

Authors:  G Gallacher; C S Jackson; M Searcey; G T Badman; R Goel; C M Topham; G W Mellor; K Brocklehurst
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

10.  Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.

Authors:  G Gallacher; C S Jackson; M Searcey; R Goel; G W Mellor; C Z Smith; K Brocklehurst
Journal:  Eur J Biochem       Date:  1993-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.